Experimental studies of serum and intracellular hyperuricemic models have found that hyperuricemia causes renal arterionephrosclerosis/arteriolopathy owing to the activation of the renin–angiotensin–aldosterone system35,37 and decreased nitric oxide bioavailability35,37. The gene discussed is REN; the disease is hyperuricemia.